Cargando...

A Nanoparticle Based Sp17 Peptide Vaccine Exposes New Immuno-Dominant and Species Cross-reactive B Cell Epitopes

Sperm protein antigen 17 (Sp17), expressed in primary as well as in metastatic lesions in >83% of patients with ovarian cancer, is a promising ovarian cancer vaccine candidate. Herein we describe the formulation of nanoparticle based vaccines based on human Sp17 (hSp17) sequence derived peptides,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Vaccines (Basel)
Autores principales: Xiang, Sue D., Gao, Qian, Wilson, Kirsty L., Heyerick, Arne, Plebanski, Magdalena
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2015
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4693223/
https://ncbi.nlm.nih.gov/pubmed/26529027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines3040875
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!